Plasma and synovial fluid as solvents for monosodium urate.
AUTOR(ES)
Dorner, R W
RESUMO
In-vitro differences in monosodium urate (MSU) crystal dissolution in paired plasma and synovial fluid samples from patients with various arthritides were studied. Plasma was a significantly better solvent for MSU than synovial fluid (overall difference 6.3 mg/dl (0.37 mmol/l); significant at P less than 0.001). Attempts to correlate the solubility differentials with the principal compositional differences between the 2 fluids were only partially successful. (1) A tendency towards higher MSU solubility at higher protein levels was observed, but it was too slight to reach statistical significance. (2) Hyaluronidase treatment of synovial fluid significantly enhanced its ability to dissolve MSU (overall difference 2.2 mg/dl (0.13 mmol/l); significant at P less than 0.01) but not sufficiently to explain wholly the plasma-synovial fluid differential.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1000660Documentos Relacionados
- Mechanism for calcium urolithiasis among patients with hyperuricosuria: supersaturation of urine with respect to monosodium urate.
- Growth of monosodium urate monohydrate crystals: effect of cartilage and synovial fluid components on in vitro growth rates.
- Evidence for a promoter of urate crystal formation in gouty synovial fluid.
- Nucleation of monosodium urate crystals.
- Hypoxanthine, xanthine, and urate in synovial fluid from patients with inflammatory arthritides.
